{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T12:54:16Z","timestamp":1780318456330,"version":"3.54.1"},"reference-count":22,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,13]],"date-time":"2021-09-13T00:00:00Z","timestamp":1631491200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100014382","name":"Ipsen Pharma SA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014382","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008349","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016025","name":"American Association for Anatomy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003982","name":"ITM University-Gwalior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003982","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.clinthera.2021.08.014","type":"journal-article","created":{"date-parts":[[2021,9,28]],"date-time":"2021-09-28T08:56:04Z","timestamp":1632819364000},"page":"1779-1785","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Weight Maintenance up to 48 Weeks in Patients With Carcinoid Syndrome Treated With Telotristat Ethyl: Pooled Data From the Open-Label Extensions of the Phase III Clinical Trials TELESTAR and TELECAST"],"prefix":"10.1016","volume":"43","author":[{"given":"Rajaventhan","family":"Srirajaskanthan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Pavel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Kulke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Clement","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6248-8986","authenticated-orcid":false,"given":"Aude","family":"Houchard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucie","family":"Keeber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin O.","family":"Weickert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2021.08.014_bib0001","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1001\/jamaoncol.2017.0589","article-title":"Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States","volume":"3","author":"Dasari","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.clinthera.2021.08.014_bib0002","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1200\/JGO.2015.002980","article-title":"Patient-reported burden of a neuroendocrine tumor (NET) diagnosis: results from the first global survey of patients with NETs","volume":"3","author":"Singh","year":"2017","journal-title":"J Glob Oncol"},{"key":"10.1016\/j.clinthera.2021.08.014_bib0003","doi-asserted-by":"crossref","first-page":"e398","DOI":"10.1503\/cmaj.160771","article-title":"Principles of diagnosis and management of neuroendocrine tumours","volume":"189","author":"Raphael","year":"2017","journal-title":"CMAJ"},{"key":"10.1016\/j.clinthera.2021.08.014_bib0004","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1053\/j.gastro.2008.05.047","article-title":"Gastrointestinal neuroendocrine tumors: pancreatic endocrine tumors","volume":"135","author":"Metz","year":"2008","journal-title":"Gastroenterology"},{"issue":"suppl 7","key":"10.1016\/j.clinthera.2021.08.014_bib0005","doi-asserted-by":"crossref","first-page":"vii72","DOI":"10.1093\/annonc\/mdq290","article-title":"Gastrointestinal neuroendocrine tumors","volume":"21","author":"\u00d6berg","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clinthera.2021.08.014_bib0006","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S1470-2045(17)30110-9","article-title":"Frequency of carcinoid syndrome at neuroendocrine tumour diagnosis: a population-based study","volume":"18","author":"Halperin","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clinthera.2021.08.014_bib0007","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.jacc.2016.12.030","article-title":"Diagnosing and managing carcinoid heart disease in patients with neuroendocrine tumors: an expert statement","volume":"69","author":"Davar","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.clinthera.2021.08.014_bib0008","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1097\/MPA.0000000000000818","article-title":"Patient-reported experience of diagnosis, management, and burden of neuroendocrine tumors: results from a large patient survey in the United States","volume":"46","author":"Wolin","year":"2017","journal-title":"Pancreas"},{"key":"10.1016\/j.clinthera.2021.08.014_bib0009","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1097\/MPA.0000000000001384","article-title":"Management of diarrhea in patients with carcinoid syndrome","volume":"48","author":"Naraev","year":"2019","journal-title":"Pancreas"},{"key":"10.1016\/j.clinthera.2021.08.014_bib0010","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/MPA.0b013e3182328045","article-title":"Comparison of health-related quality of life in patients with neuroendocrine tumors with quality of life in the general US population","volume":"41","author":"Beaumont","year":"2012","journal-title":"Pancreas"},{"key":"10.1016\/j.clinthera.2021.08.014_bib0011","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1097\/MPA.0b013e3181ebb2a5","article-title":"The NANETS consensus guideline for the diagnosis and management of neuroendocrine tumors: well-differentiated neuroendocrine tumors of the jejunum, ileum, appendix, and cecum","volume":"39","author":"Boudreaux","year":"2010","journal-title":"Pancreas"},{"key":"10.1016\/j.clinthera.2021.08.014_bib0012","unstructured":"European Commission. Commission Implementing Decision of 18.9.2017 granting marketing authorisation under Regulation (EC) No 726\/2004 of the European Parliament and of the Council for \"Xermelo - telotristat,\" an orphan medicinal product for human use. 2017."},{"key":"10.1016\/j.clinthera.2021.08.014_bib0013","unstructured":"Xermelo (telotristat ethyl) tablets. US Food and Drug Administration, 2017. Available at: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2017\/208794Orig1s000TOC.cfm."},{"key":"10.1016\/j.clinthera.2021.08.014_bib0014","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1200\/JCO.2016.69.2780","article-title":"Telotristat ethyl, a tryptophan hydroxylase inhibitor for the treatment of carcinoid syndrome","volume":"35","author":"Kulke","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clinthera.2021.08.014_bib0015","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1530\/ERC-17-0455","article-title":"Telotristat ethyl in carcinoid syndrome: safety and efficacy in the TELECAST phase 3 trial","volume":"25","author":"Pavel","year":"2018","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.clinthera.2021.08.014_bib0016","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.clinthera.2018.04.006","article-title":"Changes in weight associated with telotristat ethyl in the treatment of carcinoid syndrome","volume":"40","author":"Weickert","year":"2018","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinthera.2021.08.014_bib0017","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1159\/000442983","article-title":"Malnutrition predicts clinical outcome in patients with neuroendocrine neoplasia","volume":"104","author":"Maasberg","year":"2017","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.clinthera.2021.08.014_bib0018","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-010765","article-title":"Screening for malnutrition in patients with gastro-entero-pancreatic neuroendocrine tumours: a cross-sectional study","volume":"6","author":"Qureshi","year":"2016","journal-title":"BMJ Open"},{"key":"10.1016\/j.clinthera.2021.08.014_bib0019","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.3748\/wjg.v25.i10.1171","article-title":"Nutritional and vitamin status in patients with neuroendocrine neoplasms","volume":"25","author":"Clement","year":"2019","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.clinthera.2021.08.014_bib0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4158\/EP14203.OR","article-title":"Decreased inpatient mortality in obese patients with abdominal nets","author":"Glazer","year":"2014","journal-title":"Endocr Pract"},{"key":"10.1016\/j.clinthera.2021.08.014_bib0021","doi-asserted-by":"crossref","first-page":"e662","DOI":"10.1634\/theoncologist.2018-0236","article-title":"Long-term safety experience with telotristat ethyl across five clinical studies in patients with carcinoid syndrome","volume":"24","author":"Anthony","year":"2019","journal-title":"Oncologist"},{"key":"10.1016\/j.clinthera.2021.08.014_bib0022","series-title":"Xermelo Patient Registry: Improvements in Clinical Outcomes, Patients Satisfaction, and Weight With Telotristat Ethyl in the Real-World","author":"Price","year":"2019"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291821003131?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291821003131?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T08:57:20Z","timestamp":1758963440000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291821003131"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":22,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S0149291821003131"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2021.08.014","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Weight Maintenance up to 48 Weeks in Patients With Carcinoid Syndrome Treated With Telotristat Ethyl: Pooled Data From the Open-Label Extensions of the Phase III Clinical Trials TELESTAR and TELECAST","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2021.08.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}